Current Treatment Options in Allergy最新文献_第6页

Impact in Contact Dermatitis during and after SARS-CoV2 Pandemic. SARS-CoV2大流行期间和之后对接触性皮炎的影响

IF 1.1

Current Treatment Options in Allergy Pub Date : 2022-01-01 Epub Date: 2022-02-10 DOI: 10.1007/s40521-022-00298-2

Graziella Babino, Giuseppe Argenziano, Anna Balato

{"title":"Impact in Contact Dermatitis during and after SARS-CoV2 Pandemic.","authors":"Graziella Babino, Giuseppe Argenziano, Anna Balato","doi":"10.1007/s40521-022-00298-2","DOIUrl":"https://doi.org/10.1007/s40521-022-00298-2","url":null,"abstract":"Purpose of the review: Due to the recent COVID-19 pandemic, several skin conditions have emerged due to the preventive measures adopted by both health care workers and the general population against SARS-CoV-2. Above all, wearing of personal protective equipment, frequent hand-washing and disinfecting of surfaces have resulted in an increased risk of irritant or allergic contact dermatitis. The aim of this review is to investigate contact dermatitis associated with COVID-19 pandemic period.Recent findings: There is a real evidence of the rising prevalence of irritant and allergic contact dermatitis in response to the COVID-19 pandemic. The most commonly recorded symptoms are dryness, itch and redness of the skin. Nasal bridge, cheeks, forehead and hands represent the mainly affected skin sites.Summary: Contact dermatitis lesions may appear as a result of various recommendations to prevent transmission of COVID-19. Procedures to alleviate pressure and friction, gentle skin care and adequate moisturizing, have been identified as important preventive strategies for contact dermatitis related to personal protective equipment and personal hygiene measures.","PeriodicalId":36209,"journal":{"name":"Current Treatment Options in Allergy","volume":"9 1","pages":"19-26"},"PeriodicalIF":1.1,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8830973/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39642096","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 7

New Biomarkers in Anaphylaxis (Beyond Tryptase). 过敏反应的新生物标志物(除了胰蛋白酶)。

IF 1.1

Current Treatment Options in Allergy Pub Date : 2022-01-01 DOI: 10.1007/s40521-022-00326-1

P Galvan-Blasco, J Gil-Serrano, A Sala-Cunill

引用次数: 3

Management of post-COVID-19 olfactory dysfunction. covid -19后嗅觉功能障碍的管理。

IF 1.1

Current Treatment Options in Allergy Pub Date : 2022-01-01 Epub Date: 2022-01-04 DOI: 10.1007/s40521-021-00297-9

Tara J Wu, Alice C Yu, Jivianne T Lee

{"title":"Management of post-COVID-19 olfactory dysfunction.","authors":"Tara J Wu, Alice C Yu, Jivianne T Lee","doi":"10.1007/s40521-021-00297-9","DOIUrl":"https://doi.org/10.1007/s40521-021-00297-9","url":null,"abstract":"Purpose of review: Olfactory dysfunction is a frequent complication of SARS-CoV-2 infection. This review presents the current literature regarding the management of post-COVID-19 olfactory dysfunction (PCOD).Recent findings: A systematic review of the literature using the PubMed/MEDLINE, EMBASE, and Cochrane databases for the following keywords, \"Covid-19,\" \"SARS-CoV-2,\" \"anosmia,\" \"olfactory,\" \"treatment,\" and \"management\" was performed. While most cases of post-COVID-19 olfactory dysfunction resolve spontaneously within 2 weeks of symptom onset, patients with symptoms that persist past 2 weeks require medical management. The intervention with the greatest degree of supporting evidence is olfactory training, wherein patients are repeatedly exposed to potent olfactory stimuli. To date, no large-scale randomized clinical trials exist that examine the efficacy of pharmacologic therapies for PCOD. Limited clinical trials and prospective controlled trials suggest intranasal corticosteroids and oral corticosteroids may alleviate symptoms.Summary: Olfactory training should be initiated as soon as possible for patients with PCOD. Patients may benefit from a limited intranasal or oral corticosteroid course. Further research on effective pharmacologic therapies for PCOD is required to manage the growing number of patients with this condition.","PeriodicalId":36209,"journal":{"name":"Current Treatment Options in Allergy","volume":"9 1","pages":"1-18"},"PeriodicalIF":1.1,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8723803/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39914644","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 22

Shifts in Asthma Evaluation and Management During COVID-19. COVID-19期间哮喘评估和管理的转变

IF 1.9

Current Treatment Options in Allergy Pub Date : 2022-01-01 Epub Date: 2022-05-13 DOI: 10.1007/s40521-022-00304-7

Connie H Lin, Daniel A Cerrone

{"title":"Shifts in Asthma Evaluation and Management During COVID-19.","authors":"Connie H Lin, Daniel A Cerrone","doi":"10.1007/s40521-022-00304-7","DOIUrl":"10.1007/s40521-022-00304-7","url":null,"abstract":"Purpose of review: The comprehensive management of asthma has historically relied on in-person visits to obtain a detailed history, thorough physical exam, and diagnostic and monitoring tools such as pulmonary function testing. The COVID-19 pandemic has posed numerous challenges to adequately utilizing these strategies. Despite these limitations, telemedicine has provided an important means to deliver asthma care. In this review, we discuss how these challenges have created paradigm shifts in not only the clinical aspects of asthma management, but also in patient attitudes and physician-patient relationships.Recent findings: Different strategies have been suggested to address asthma during COVID-19. Telemedicine has taken on an important role during the pandemic. The emphasis on asthma questionnaire use, education regarding lapsed asthma control, and as-needed oral corticosteroid courses have proven to be important instruments in the remote management of asthma. Overall, asthma exacerbations have decreased during this time. This is thought to be due to a variety of factors such as decreased exposure to common triggers.Summary: Although the COVID-19 pandemic significantly limited an allergist's ability to provide conventional comprehensive asthma management, we also found that patient outcomes have actually improved. In addition to the decreased exposure to asthma triggers, this may also be an effect of increased patient ownership of their asthma, and subsequent improved therapeutic alliance.","PeriodicalId":36209,"journal":{"name":"Current Treatment Options in Allergy","volume":"9 1","pages":"42-51"},"PeriodicalIF":1.9,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9099326/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41493322","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

The Role of Basophil Activation Test in Drug Allergy 嗜碱性粒细胞激活试验在药物过敏中的作用

IF 1.1

Current Treatment Options in Allergy Pub Date : 2021-12-01 DOI: 10.1007/s40521-021-00294-y

F. R., G. Bogas, M. Salas, L. Jj, Fernandez Td, Torres-Anjel Mj, Mayorga C

引用次数: 2

The Role of Airborne Pollutants in Chronic Rhinosinusitis 空气污染物在慢性鼻窦炎中的作用

IF 1.1

Current Treatment Options in Allergy Pub Date : 2021-11-04 DOI: 10.1007/s40521-021-00296-w

Justin P. McCormick, Jivianne T. Lee

引用次数: 3

Risk stratification in beta-lactam allergy β-内酰胺过敏的风险分层

IF 1.1

Current Treatment Options in Allergy Pub Date : 2021-10-16 DOI: 10.1007/s40521-021-00295-x

T. Arıkoğlu, Aylin Kont, A. Demirhan, B. Yuksek, Nazan Tokmeci, S. Kuyucu

引用次数: 0

Hypersensitivity Reactions to Non-Beta Lactam Antibiotics 非内酰胺类抗生素的超敏反应

IF 1.1

Current Treatment Options in Allergy Pub Date : 2021-08-26 DOI: 10.1007/s40521-021-00293-z

A. Gelincik, S. Demir

引用次数: 0

Diagnosing and Managing Patients with Reactions to Radiocontrast Media 放射性造影剂反应患者的诊断和管理

IF 1.1

Current Treatment Options in Allergy Pub Date : 2021-08-23 DOI: 10.1007/s40521-021-00287-x

K. Brockow

引用次数: 0

Peanut Immunotherapy: Practical Applications 花生免疫疗法:实际应用

IF 1.1

Current Treatment Options in Allergy Pub Date : 2021-05-31 DOI: 10.1007/s40521-021-00292-0

Olivia Francis, Edwin H. Kim

引用次数: 0